Aytu BioPharma, Inc.
Index- P/E- EPS (ttm)-3.74 Insider Own0.30% Shs Outstand26.41M Perf Week8.91%
Market Cap17.11M Forward P/E- EPS next Y-0.91 Insider Trans0.00% Shs Float26.38M Perf Month-12.46%
Income-83.90M PEG- EPS next Q-0.41 Inst Own20.20% Short Float6.37% Perf Quarter-57.41%
Sales82.00M P/S0.21 EPS this Y-15.50% Inst Trans54.88% Short Ratio1.63 Perf Half Y-71.61%
Book/sh4.00 P/B0.14 EPS next Y55.50% ROA-33.90% Target Price11.00 Perf Year-90.07%
Cash/sh1.16 P/C0.48 EPS next 5Y- ROE-67.40% 52W Range0.45 - 6.18 Perf YTD-58.36%
Dividend- P/FCF- EPS past 5Y- ROI-37.40% 52W High-90.90% Beta-0.03
Dividend %- Quick Ratio0.70 Sales past 5Y91.30% Gross Margin42.80% 52W Low24.93% ATR0.07
Employees175 Current Ratio0.90 Sales Q/Q53.00% Oper. Margin- RSI (14)38.98 Volatility8.74% 10.81%
OptionableYes Debt/Eq0.22 EPS Q/Q39.00% Profit Margin- Rel Volume0.13 Prev Close0.54
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.03M Price0.56
Recom2.00 SMA20-2.46% SMA50-33.77% SMA200-70.09% Volume134,935 Change4.11%
Mar-30-21Initiated Cantor Fitzgerald Overweight $11
May-29-20Initiated H.C. Wainwright Buy $3
May-17-22 07:29AM  
May-16-22 04:02PM  
Apr-25-22 08:00AM  
Apr-19-22 08:00AM  
Mar-23-22 08:00AM  
Mar-22-22 08:00AM  
Mar-08-22 08:00AM  
Mar-07-22 04:05PM  
Mar-02-22 08:00PM  
Feb-18-22 09:40AM  
Feb-14-22 04:05PM  
Jan-31-22 08:00AM  
Jan-04-22 08:00AM  
Jan-03-22 08:00AM  
Dec-14-21 09:30AM  
Dec-13-21 08:00AM  
Dec-09-21 11:38AM  
Dec-08-21 08:00AM  
Nov-23-21 08:00AM  
Nov-17-21 08:00AM  
Nov-15-21 04:00PM  
Nov-08-21 08:05AM  
Nov-04-21 03:01PM  
Oct-04-21 04:49PM  
Sep-30-21 08:01AM  
Sep-29-21 06:49AM  
Sep-27-21 04:01PM  
Sep-23-21 08:00AM  
Sep-09-21 08:00AM  
Sep-08-21 07:00AM  
Sep-07-21 08:00AM  
Jul-27-21 08:05AM  
Jul-07-21 08:43AM  
Jun-28-21 08:50AM  
Jun-20-21 02:13PM  
May-25-21 08:01AM  
May-17-21 04:01PM  
May-15-21 03:28AM  
May-12-21 10:50AM  
May-10-21 04:01PM  
Apr-12-21 08:00AM  
Apr-05-21 08:00AM  
Apr-02-21 05:05AM  
Apr-01-21 07:30AM  
Mar-22-21 06:00AM  
Mar-18-21 05:34PM  
Mar-12-21 08:00AM  
Mar-09-21 08:08AM  
Mar-08-21 03:01PM  
Feb-24-21 08:00AM  
Feb-14-21 01:41AM  
Feb-11-21 04:01PM  
Feb-10-21 08:00AM  
Feb-08-21 06:57AM  
Feb-04-21 08:00AM  
Jan-06-21 07:58AM  
Dec-28-20 08:05AM  
Dec-24-20 10:49PM  
Dec-16-20 09:20PM  
Dec-15-20 12:00PM  
Dec-14-20 08:01AM  
Dec-11-20 11:41AM  
Dec-10-20 11:10PM  
Dec-09-20 10:30AM  
Nov-26-20 06:33PM  
Nov-12-20 04:01PM  
Nov-11-20 08:00AM  
Nov-05-20 08:00AM  
Oct-06-20 05:37PM  
Oct-05-20 10:05AM  
Sep-23-20 06:00PM  
Sep-16-20 08:00AM  
Sep-08-20 08:00AM  
Aug-19-20 08:00AM  
Aug-17-20 11:35AM  
Aug-05-20 11:04AM  
Aug-04-20 11:56AM  
Jul-31-20 05:45PM  
Jul-30-20 08:00AM  
Jul-27-20 08:00AM  
Jul-20-20 07:30AM  
Jul-10-20 08:00AM  
Jul-07-20 11:30AM  
Jun-25-20 12:00PM  
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.